尔康制药：聘任证券事务代表

Core Viewpoint - The company has appointed Ms. Wang Rong as the representative for securities affairs, as approved by the board of directors [1] Group 1 - The appointment of Ms. Wang Rong is aimed at enhancing the company's communication and transparency with investors [1] - The decision reflects the company's commitment to improving its governance structure [1]